End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,629 MXN | +1.22% |
|
-.--% | -.--% |
Sales 2024 * | 46.35B 49.79B 914B 4,150B | Sales 2025 * | 49.8B 53.49B 982B 4,458B | Capitalization | 115B 123B 2,264B 10,280B |
---|---|---|---|---|---|
Net income 2024 * | 7.08B 7.61B 140B 634B | Net income 2025 * | 8.69B 9.33B 171B 778B | EV / Sales 2024 * | 2.63 x |
Net Debt 2024 * | 6.99B 7.51B 138B 626B | Net Debt 2025 * | 2.37B 2.54B 46.71B 212B | EV / Sales 2025 * | 2.35 x |
P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
13
x | Employees | 86,088 |
Yield 2024 * |
4.3% | Yield 2025 * |
4.53% | Free-Float | 87.13% |
Latest transcript on Sanofi
1 day | +1.22% |
![Extreme 1609.59](/images/extremecours_fleche.png)
![Extreme 1531.92](/images/extremecours_fleche.png)
![Extreme 1531.92](/images/extremecours_fleche.png)
![Extreme 1531.92](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01/19/01 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01/22/01 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01/14/01 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22/20/22 |
Frédéric Oudéa
CHM | Chairman | 61 | 02/22/02 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- SAN Stock
- SAN1 N Stock